We found that IV anti-CD45

We found that IV anti-CD45.2 antibody injection rapidly (within one minute) labeled blood contiguous Remodelin Hydrobromide T cells in the spleen, bone marrow, and liver. AF647, resulted in continuous blood leukocyte labeling for over 6 hours. Finally, we leveraged IP anti-CD45.2 BB700 antibody to track slower migrating leukocytes into tumors. We found that IP anti-CD45.2 antibody injection allowed for the identification of ~seven Remodelin Hydrobromide times as many tumor-specific CD8+T cells that had recently migrated from blood into tumors. Our results demonstrate how different injection routes and fluorophores affect anti-CD45.2 antibody leukocyte labeling and highlight the utility of this approach for defining leukocyte migration in the context of homeostasis and cancer. Keywords:T cell migration,In vivolabeling, Route of injection, Blood Contiguous Organs == INTRODUCTION == To protect the host from homeostatic perturbations, including infection and cancer, leukocytes must migrate from the blood into tissue1. Leukocyte trafficking in both homeostasis and inflammation is a highly orchestrated process, involving combinations of selectins, chemokine receptors, and integrins24. After binding their requisite ligands, immune cells roll and arrest on vascular endothelium before extravasating and entering tissue1. While these migration mechanisms are well defined in multiple contexts, identifying leukocytes that had recently trafficked to tissue has, up until recently58, remained a significant challenge in the field. Prior work examining the rate at which immune cells migrate into tissues have used a variety of LAMP3 different techniques and modalities. The gold standard approach for examining leukocyte turnover in tissues has been parabiosis, which involves making mirrored skin incisions on the flanks of two mice, and then physically conjoining animals using sutures or surgical staples9. Over the course of several days, the vasculature fuses between the two mice and blood leukocytes equilibrate over the course of roughly one week9. Alternatively, photoconvertible protein reporters, which change fluorescence properties for a defined period of time after laser excitation, have also allowed for the assessment of leukocyte replacement and egress rates in laser accessible tissue locations1012. However, both methodologies have significant drawbacks. Recent work over the last several years has demonstrated that intravenous (IV) injection of anti-CD45 antibodies in non-human primates and mice allows for tracking of leukocyte migration from blood to tissues58. Indeed, we recently demonstrated that in mice, IV anti-CD45.2 antibody 1) actively bound to cellsin vivofor roughly 45 Remodelin Hydrobromide minutes, 2) remained cell associated for approximately 72 hours, 3) did not leak from the vasculature into tissue, 4) Remodelin Hydrobromide could be injected multiple (>5) times without blocking or saturating available CD45.2, and 5) did not deplete CD45.2+cells or change their activation status7. We previously used this technique to identify migration of leukocytes into tumors. However, while this method allowed for tracking leukocyte populations that rapidly entered tissues, rarer migration events were difficult to capture due to a limited active binding window. Therefore, we interrogated whether modifications could be made to delivery route and/or fluorophore to further optimize the labeling technique and expand the labeling window, enabling the detection of greater numbers of trafficking leukocytes. The peritoneal cavity is an important anatomic site, containing numerous visceral organs, immune cells, and serous fluid that helps to maintain organ homeostasis13. Research over many decades has demonstrated that protein or pathogen injection into the peritoneal cavity results in systemic dissemination through the vasculature14,15. This is not due to direct absorption from the peritoneal space into the blood, but rather due to lymphatic drainage into the thoracic duct14,16. Indeed, using fluorescent tracers, previous work demonstrated that compounds injected into the peritoneum were found in both paravertebral and diaphragmatic lymphatic vessels16. More Remodelin Hydrobromide recently it was shown that initial drainage was mediated by specialized capillary mesenteric lymphatic vessels that bypassed mesenteric lymph nodes and shuttled peritoneal fluid directly into the mediastinal lymph node before emptying into the thoracic duct17. Because compounds injected into the peritoneal cavity must drain through lymphatics and the mediastinal lymph node, there is a temporal delay before they can be found in blood14. Concordantly, antibody injected into the peritoneal cavity slowly increases in concentration over time in mice14. These data suggest that antibody injection into the peritoneal cavity may represent an alternative route to slowly release anti-CD45.2 antibody into blood over time, potentially increasing the window to.